Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug…
PHARMA & CLINICAL TRIALS


Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1…


A scientific technique that rapidly increases the body’s production of anti-inflammatory cells promoted healing from…


With tinier needles and fewer injections, the approach may enable new options for long-term delivery…


A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in…